These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2508153)

  • 1. Comparison of the effects of four cholinomimetic agents on cognition in primates following disruption by scopolamine or by lists of objects.
    Rupniak NM; Steventon MJ; Field MJ; Jennings CA; Iversen SD
    Psychopharmacology (Berl); 1989; 99(2):189-95. PubMed ID: 2508153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate models.
    Rupniak NM; Field MJ; Samson NA; Steventon MJ; Iversen SD
    Neurobiol Aging; 1990; 11(6):609-13. PubMed ID: 2280804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze.
    Dennes RP; Barnes JC
    Psychopharmacology (Berl); 1993; 111(4):435-41. PubMed ID: 7870985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholinergic drugs on scopolamine-induced memory impairment in rhesus monkeys.
    Hironaka N; Ando K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Jun; 16(3):103-8. PubMed ID: 8905798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cholinergic drugs on prey-killing by rodents.
    Wnek DJ; Leaf RC
    Physiol Behav; 1973 Jun; 10(6):1107-13. PubMed ID: 4736903
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced performance of spatial and visual recognition memory tasks by the selective acetylcholinesterase inhibitor E2020 in rhesus monkeys.
    Rupniak NM; Tye SJ; Field MJ
    Psychopharmacology (Berl); 1997 Jun; 131(4):406-10. PubMed ID: 9226744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemicholinium-3 impairs spatial learning and the deficit is reversed by cholinomimetics.
    Hagan JJ; Jansen JH; Broekkamp CL
    Psychopharmacology (Berl); 1989; 98(3):347-56. PubMed ID: 2526345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cholinergic agonists on the dorsal immobility response.
    Potter TJ; Cottrell GA; Van Hartesveldt C
    Pharmacol Biochem Behav; 1990 May; 36(1):77-80. PubMed ID: 2349272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of physostigmine and scopolamine on recognition memory in monkeys.
    Aigner TG; Mishkin M
    Behav Neural Biol; 1986 Jan; 45(1):81-7. PubMed ID: 3954717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence against a specific effect of cholinergic drugs on spatial memory in primates.
    Rupniak NM; Samson NA; Tye SJ; Field MJ; Iversen SD
    Behav Brain Res; 1991 Apr; 43(1):1-6. PubMed ID: 1859616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cholinergic system and nociception in the primate: interactions with morphine.
    Pert A
    Psychopharmacologia; 1975 Oct; 44(2):131-7. PubMed ID: 708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of delta9-tetrahydrocannabinol with cholinomimetic drugs in an agonist-antagonist paradigm.
    Jones BC; Consroe PF; Laird HE
    Eur J Pharmacol; 1976 Aug; 38(2):253-9. PubMed ID: 954840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of cognitive impairment by heptyl physostigmine, a long-lasting cholinesterase inhibitor, in primates.
    Rupniak NM; Tye SJ; Brazell C; Heald A; Iversen SD; Pagella PG
    J Neurol Sci; 1992 Feb; 107(2):246-9. PubMed ID: 1564524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus properties of muscarinic agonists.
    Jung M; Costa L; Shearman GT; Kelly PH
    Psychopharmacology (Berl); 1987; 93(2):139-45. PubMed ID: 3122245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat.
    Salamone JD; Lalies MD; Channell SL; Iversen SD
    Psychopharmacology (Berl); 1986; 88(4):467-71. PubMed ID: 3085134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of selective and nonselective muscarinic agonists on cognition and thermoregulation in primates.
    Rupniak NM; Tye SJ; Iversen SD
    J Neurol Sci; 1992 Jul; 110(1-2):222-7. PubMed ID: 1506863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacology fo gross behavioural effects of cholinomimetic substances injected into the cerebral ventricles of unanaesthetized cats: evidence for central muscarinic mediation.
    Beleslin DB; Grabović L; Radmanović BZ
    Neuropharmacology; 1974 Dec; 13(12):1163-9. PubMed ID: 4457763
    [No Abstract]   [Full Text] [Related]  

  • 19. N-tert-butyl-alpha-phenylnitrone, a free radical scavenger with anticholinesterase activity does not improve the cognitive performance of scopolamine-challenged rats.
    Milivojevic N; Babic K; Milatovic D; Dettbarn WD; Sket D; Zivin M
    Int J Dev Neurosci; 2001 Jun; 19(3):319-25. PubMed ID: 11337201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, improves visual recognition memory in rhesus monkeys: comparison with physostigmine.
    Matsuoka N; Aigner TG
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1201-9. PubMed ID: 9067304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.